Revive Therapeutics Ltd (RVVTF)

[Ecomike]

Good evening sir. I see reading comprehension, is either still lacking in most of flipper world or is it that selective quote parroting by the molesters of stocks and stock news like the recent $RVVTF great news, to the reading comprehension challenged trading shorted stocks these days is the primary issue?

Like you, I see news that I predicted that is great news.

https://www.stocktitan.net/news/RVVTF/revive-therapeutics-provides-update-of-phase-3-clinical-study-for-3x0it6c60rx7.html

the Company has halted the Study and will now proceed to unblind and seek an evaluation of the Study’s data, including the COVID-19 clinical symptoms data (i.e. cough, fever, heart rate, and oxygen saturation) to determine the potential next clinical and regulatory steps for Bucillamine. The Company believes that once it has completed the evaluation of the Study’s data, it could support further discussions with the FDA on potential new clinical studies and allow the opportunity to work with potential domestic and international pharmaceutical partners to determine a suitable regulatory pathway for approval of Bucillamine based on the evaluated Study’s data.

The Company is committed to advancing the clinical and commercial development of Bucillamine and plans to pursue the following activities:

Continue discussions with the FDA on a pathway for future potential clinical studies for regulatory approval under proposed new efficacy endpoints based on the evaluation of the Study’s data;
Work with interested pharmaceutical partners to pursue potential domestic and international regulatory approvals and new clinical studies for Long COVID or COVID symptom-related conditions and various infectious, inflammatory and respiratory disorders; and
Develop reformulation strategies of Bucillamine to expand on its potential therapeutic utility targeting rare disorders that may come with regulatory incentives awarded by the FDA, such as orphan drug (i.e. ischemia-reperfusion injury, cystinuria), fast track, and breakthrough therapy designations.

At this time, the Company will only provide regular updates via press releases as information becomes available.

No doubt this last part

"At this time, the Company will only provide regular updates via press releases as information becomes available"

annoyed the common stock molesters and flippers that want daily news feedings with their coffee and Donuts?